Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
- PMID: 26916412
- PMCID: PMC4828323
- DOI: 10.1002/cncr.29926
Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco
Abstract
Smoking cessation is crucial for reducing cancer risk and premature mortality. The US Preventive Services Task Force (USPSTF) has recommended annual lung cancer screening with low-dose computed tomography (LDCT), and the Center for Medicare and Medicaid Services recently approved lung screening as a benefit for patients ages 55 to 77 years who have a 30 pack-year history. The Society for Research on Nicotine and Tobacco (SRNT) and the Association for the Treatment of Tobacco Use and Dependence (ATTUD) developed the guideline described in this commentary based on an illustrative literature review to present the evidence for smoking-cessation health benefits in this high-risk group and to provide clinical recommendations for integrating evidence-based smoking-cessation treatment with lung cancer screening. Unfortunately, extant data on lung cancer screening participants were scarce at the time this guideline was written. However, in this review, the authors summarize the sufficient evidence on the benefits of smoking cessation and the efficacy of smoking-cessation interventions for smokers ages 55 to 77 years to provide smoking-cessation interventions for smokers who seek lung cancer screening. It is concluded that smokers who present for lung cancer screening should be encouraged to quit smoking at each visit. Access to evidence-based smoking-cessation interventions should be provided to all smokers regardless of scan results, and motivation to quit should not be a necessary precondition for treatment. Follow-up contacts to support smoking-cessation efforts should be arranged for smokers. Evidence-based behavioral strategies should be used at each visit to motivate smokers who are unwilling to try quitting/reducing smoking or to try evidence-based treatments that may lead to eventual cessation.
Keywords: cigarette smoking; lung cancer screening prevention; smoking cessation; tobacco.
© 2016 American Cancer Society.
Conflict of interest statement
CONFLICT OF INTEREST DISCLOSURES
Benjamin A. Toll reports commercial research grants and support in excess of $10,000 from Pfizer for medicine only. The remaining authors made no disclosures. Conflict of interest statements from the Writing Work Group were obtained and are on file with the Society for Research on Nicotine and Tobacco.
Similar articles
-
Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.Transl Behav Med. 2022 Nov 21;12(11):1076-1083. doi: 10.1093/tbm/ibac076. Transl Behav Med. 2022. PMID: 36227937 Free PMC article.
-
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.JAMA. 2021 Mar 9;325(10):988-997. doi: 10.1001/jama.2021.1077. JAMA. 2021. PMID: 33687469 Free PMC article.
-
Lung Cancer Screening Eligibility, Risk Perceptions, and Clinician Delivery of Tobacco Cessation Among Patients With Schizophrenia.Psychiatr Serv. 2019 Oct 1;70(10):927-934. doi: 10.1176/appi.ps.201900044. Epub 2019 Jul 30. Psychiatr Serv. 2019. PMID: 31357921 Free PMC article.
-
Lung Cancer Screening.Med Clin North Am. 2017 Jul;101(4):769-785. doi: 10.1016/j.mcna.2017.03.008. Med Clin North Am. 2017. PMID: 28577626 Free PMC article. Review.
-
Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration.Am J Respir Crit Care Med. 2018 Jan 15;197(2):172-182. doi: 10.1164/rccm.201705-0909CI. Am J Respir Crit Care Med. 2018. PMID: 28977754 Free PMC article. Review.
Cited by
-
A risk-based framework for assessing real-time lung cancer screening eligibility that incorporates life expectancy and past screening findings.Cancer. 2021 Dec 1;127(23):4432-4446. doi: 10.1002/cncr.33835. Epub 2021 Aug 12. Cancer. 2021. PMID: 34383299 Free PMC article.
-
Associations between body mass index and the risk of mortality from lung cancer: A dose-response PRISMA-compliant meta-analysis of prospective cohort studies.Medicine (Baltimore). 2017 Aug;96(34):e7721. doi: 10.1097/MD.0000000000007721. Medicine (Baltimore). 2017. PMID: 28834876 Free PMC article.
-
Integrating tobacco treatment into cancer care: Study protocol for a randomized controlled comparative effectiveness trial.Contemp Clin Trials. 2016 Sep;50:54-65. doi: 10.1016/j.cct.2016.07.016. Epub 2016 Jul 19. Contemp Clin Trials. 2016. PMID: 27444428 Free PMC article. Clinical Trial.
-
Accelerating integration of tobacco use treatment in the context of lung cancer screening: Relevance and application of implementation science to achieving policy and practice.Transl Behav Med. 2022 Nov 21;12(11):1076-1083. doi: 10.1093/tbm/ibac076. Transl Behav Med. 2022. PMID: 36227937 Free PMC article.
-
Outdoor smoking in Nigeria: prevalence, correlates and predictors.BMC Public Health. 2019 Oct 21;19(1):1313. doi: 10.1186/s12889-019-7601-8. BMC Public Health. 2019. PMID: 31638945 Free PMC article.
References
-
- Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144:33–38. - PubMed
-
- National Comprehensive Cancer (NCCN) NCCN Clinical Practice Guidelines in Oncology: Lung Cancer Screening. Version 2. Fort Washington: PA: NCCN; 2014.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical